{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-099516","form_type":"8-K","ticker":"SRTS","cik":"0001494891","company_name":"Sensus Healthcare, Inc.","filed_at":"2024-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.582124+00:00","generated_at":"2026-05-29T22:58:44.214063+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sensus Q3 revenues double to $8.8M; net income $1.2M vs loss; targets >50 IG-SRT deals by year-end","bullets":["Revenue $8.8M (+127% YoY); net income $1.2M ($0.07 diluted EPS) vs net loss $1.5M ($0.09 loss) in Q3 2023.","Adjusted EBITDA $1.6M vs negative $1.7M; shipped 27 systems (11 in Q3 2023).","Signed 22 IG-SRT units under Fair Deal as of Sep 30; expects >50 by year-end, generating recurring revenue in 2025.","Cash $22.6M, no debt; gross margin improved to 59.3% from 51.0%.","Sold SRT system to Providence Swedish Hospital; strong interest at ASTRO conference."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-099516","json":"https://secwatch.observer/filing/0001213900-24-099516.json","markdown":"https://secwatch.observer/filing/0001213900-24-099516.md","text":"https://secwatch.observer/filing/0001213900-24-099516.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000121390024099516/0001213900-24-099516-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000121390024099516/ea0221591-8k_sensus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T22:58:44.214063+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}